A significant legislative overhaul in 2025 has reshaped the landscape for thousands of Texans, transforming one of the nation’s most restrictive medical cannabis programs into a system poised for substantial growth and improved patient care. This industry report analyzes the pivotal reforms to the T
In a state grappling with one of the nation's most acute healthcare shortages, New Mexico's legislature has advanced a pivotal bill aimed at reversing the exodus of medical professionals by restructuring its medical malpractice landscape. House Bill 99, which cleared the House with
The once-predictable landscape of American healthcare regulation has shattered into a mosaic of state-level mandates, leaving a national industry to navigate a chaotic and increasingly treacherous compliance environment. A prolonged federal stalemate on critical issues, from drug pricing to supply
A recently proposed overhaul to a critical drug pricing program, which threatened to disrupt the financial stability of the nation's most vulnerable hospitals, has been officially withdrawn following a swift and decisive legal battle. This development marks a significant victory for safety-net
After years of escalating pressure and legislative debate, the Consolidated Appropriations Act of 2026 has finally landed, bringing with it a wave of reforms aimed at the powerful and often opaque world of Pharmacy Benefit Managers (PBMs). Employer groups, representing the health plans of more than
For decades, the intricate and often bewildering system of prescription drug pricing in the United States has been orchestrated by powerful but little-understood intermediaries whose operations remained largely shielded from public and regulatory view. These entities, known as Pharmacy Benefit
